Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines

Circulation
Scott M GrundyAmerican Heart Association

Abstract

The Adult Treatment Panel III (ATP III) of the National Cholesterol Education Program issued an evidence-based set of guidelines on cholesterol management in 2001. Since the publication of ATP III, 5 major clinical trials of statin therapy with clinical end points have been published. These trials addressed issues that were not examined in previous clinical trials of cholesterol-lowering therapy. The present document reviews the results of these recent trials and assesses their implications for cholesterol management. Therapeutic lifestyle changes (TLC) remain an essential modality in clinical management. The trials confirm the benefit of cholesterol-lowering therapy in high-risk patients and support the ATP III treatment goal of low-density lipoprotein cholesterol (LDL-C) <100 mg/dL. They support the inclusion of patients with diabetes in the high-risk category and confirm the benefits of LDL-lowering therapy in these patients. They further confirm that older persons benefit from therapeutic lowering of LDL-C. The major recommendations for modifications to footnote the ATP III treatment algorithm are the following. In high-risk persons, the recommended LDL-C goal is <100 mg/dL, but when risk is very high, an LDL-C goal of <70 ...Continue Reading

References

Jan 27, 1975·JAMA : the Journal of the American Medical Association
Dec 1, 1986·Journal of the American College of Cardiology·P L CannerW Friedewald
Sep 1, 1994·Journal of Clinical Epidemiology·H IsoY Komachi
Dec 5, 1998·The New England Journal of Medicine·UNKNOWN Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group
Jan 6, 2001·Journal of Cardiovascular Risk·H B Rubins
Apr 13, 2001·JAMA : the Journal of the American Medical Association·G G SchwartzUNKNOWN Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) Study Investigators
May 23, 2001·JAMA : the Journal of the American Medical Association·UNKNOWN Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults
Jan 5, 2002·The New England Journal of Medicine·B G BrownJ J Albers
Oct 19, 2002·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Thomayant PrueksaritanontJiunn H Lin
Nov 30, 2002·Lancet·James ShepherdUNKNOWN PROSPER study group. PROspective Study of Pravastatin in the Elderly at Risk
Dec 20, 2002·JAMA : the Journal of the American Medical Association·UNKNOWN ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. The Antihypertensive and Lipid-Lowering Treatm
Dec 31, 2002·Journal of the American College of Cardiology·Michael H DavidsonEnrico P Veltri
Mar 14, 2003·The American Journal of Cardiology·Harold E BaysUNKNOWN ADvicor Versus Other Cholesterol-Modulating Agents Trial Evaluation
Apr 30, 2003·Diabetes Care·Sander J RobinsUNKNOWN Veterans Affairs HDL Intervention Trial (VA-HIT)
Jul 16, 2003·The American Journal of Cardiology·Peter H JonesUNKNOWN STELLAR Study Group
Jul 24, 2003·JAMA : the Journal of the American Medical Association·David J A JenkinsPhilip W Connelly
Jan 13, 2004·The American Journal of Cardiology·David D WatersUNKNOWN TNT Steering Committee Members and Investigators
Mar 5, 2004·JAMA : the Journal of the American Medical Association·Steven E NissenUNKNOWN REVERSAL Investigators
Mar 10, 2004·The New England Journal of Medicine·Christopher P CannonUNKNOWN Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 Investigators
Jun 17, 2004·American Heart Journal·Bonnie B DeanC Noel Bairey Merz

❮ Previous
Next ❯

Citations

Nov 11, 2009·Archives of Neurology·Joshua Z WilleyMitchell S V Elkind
Sep 26, 2012·Archives of Pediatrics & Adolescent Medicine·Michael TurchianoAntonio Convit
Mar 24, 2011·JAMA : the Journal of the American Medical Association·Cynthia A JackeviciusHarlan M Krumholz
Dec 16, 2006·Current Atherosclerosis Reports·Michael H Davidson
Dec 16, 2006·Current Atherosclerosis Reports·Peter A McCullough, Leslie R Rocher
Sep 1, 2006·Internal and Emergency Medicine·Daniela PoliGian Franco Gensini
Nov 3, 2006·Canadian Journal of Anaesthesia = Journal Canadien D'anesthésie·Nader N Boushra, Muhammad Muntazar
May 15, 2010·Herz·Alin Stirban
Oct 14, 2010·Herz·C H SaelyK Huber
Mar 8, 2007·Der Anaesthesist·Nils ButteP Teschendorf
May 25, 2013·Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz·C Scheidt-NaveM A Busch
Nov 13, 2004·Der Internist·A HamannP Nawroth
May 3, 2005·Der Internist·M Rosenberg, M Haass
Apr 24, 2007·Psychopharmacology·Jorge Perez-ParadaJean-Michel Le Mellédo
Jun 19, 2012·European Journal of Clinical Pharmacology·Eveliina UpmeierRisto Huupponen
Jun 16, 2009·European Journal of Nuclear Medicine and Molecular Imaging·Riemer H J A SlartRudi A Dierckx
Nov 1, 2005·Zeitschrift für Kardiologie·H Gohlke, G Schuler
Nov 1, 2005·Zeitschrift für Kardiologie·P Mathes, J Thiery
Jun 15, 2006·Clinical Research in Cardiology : Official Journal of the German Cardiac Society·Bernd Genser, Winfried März
Apr 7, 2006·Clinical Research in Cardiology : Official Journal of the German Cardiac Society·A Steinmetz
Apr 7, 2006·Clinical Research in Cardiology : Official Journal of the German Cardiac Society·E von HodenbergJ Melichercik
Jun 4, 2010·Clinical Research in Cardiology : Official Journal of the German Cardiac Society·Anselm K GittKurt Bestehorn
Oct 22, 2010·Clinical Research in Cardiology : Official Journal of the German Cardiac Society·Anselm K GittKurt Bestehorn
May 18, 2013·Clinical Research in Cardiology : Official Journal of the German Cardiac Society·Fengjuan YaoChunhua Deng
May 1, 2009·European Journal of Nutrition·Heather E RasmussenJi-Young Lee
Jun 4, 2011·Pediatric Nephrology : Journal of the International Pediatric Nephrology Association·Mohammed Sanad, Amal Gharib
Jan 12, 2007·Emergency Radiology·Hansel J Otero, Frank J Rybicki
Jun 3, 2009·Techniques in Coloproctology·A Amato
Jul 12, 2008·Clinical and Experimental Medicine·Aleksandra ZeljkovicDimitra Kalimanovska-Ostric
Jul 20, 2011·Wiener medizinische Wochenschrift·Bernhard Föger

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

Cardiology Journals

Discover the latest cardiology research in this collection of the top cardiology journals.

Related Papers

The New England Journal of Medicine
Christopher P CannonPravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 Investigators
The New England Journal of Medicine
John LaRosaTreating to New Targets (TNT) Investigators
Journal of the American College of Cardiology
Scott M GrundyCoordinating Committee of the National Cholesterol Education Program
© 2022 Meta ULC. All rights reserved